View in EDS

Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.

Saved in:
Bibliographic Details
Title: Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.
Authors: Reddy JP; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Yu Z; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Shepard RM; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Von Schalscha T; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Clague RA; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Peixoto BP; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., McCormack SJ; Alpha Beta Therapeutics, Camden, Delaware., Onaitis MW; Division of Cardiothoracic Surgery, Department of Surgery and Moores Cancer Center, University of California, San Diego, San Diego, California., Weis SM; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Cheresh DA; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Wettersten HI; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 02; Vol. 25 (3), pp. 448-456.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41081633
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reddy+JP%22">Reddy JP</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Yu+Z%22">Yu Z</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Shepard+RM%22">Shepard RM</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Von+Schalscha+T%22">Von Schalscha T</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Clague+RA%22">Clague RA</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Peixoto+BP%22">Peixoto BP</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22McCormack+SJ%22">McCormack SJ</searchLink>; Alpha Beta Therapeutics, Camden, Delaware.<br /><searchLink fieldCode="AU" term="%22Onaitis+MW%22">Onaitis MW</searchLink>; Division of Cardiothoracic Surgery, Department of Surgery and Moores Cancer Center, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Weis+SM%22">Weis SM</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Cheresh+DA%22">Cheresh DA</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Wettersten+HI%22">Wettersten HI</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 Mar 02; Vol. 25 (3), pp. 448-456.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41081633
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-25-0300
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 448
    Titles:
      – TitleFull: Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reddy JP
      – PersonEntity:
          Name:
            NameFull: Yu Z
      – PersonEntity:
          Name:
            NameFull: Shepard RM
      – PersonEntity:
          Name:
            NameFull: Von Schalscha T
      – PersonEntity:
          Name:
            NameFull: Clague RA
      – PersonEntity:
          Name:
            NameFull: Peixoto BP
      – PersonEntity:
          Name:
            NameFull: McCormack SJ
      – PersonEntity:
          Name:
            NameFull: Onaitis MW
      – PersonEntity:
          Name:
            NameFull: Weis SM
      – PersonEntity:
          Name:
            NameFull: Cheresh DA
      – PersonEntity:
          Name:
            NameFull: Wettersten HI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 03
              Text: 2026 Mar 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1